In a 13/D/A filing, the company states: “On September 9, 2024, in response to requests from the Special Committee, Ms. Wojcicki notified the members of the Special Committee that Ms. Wojcicki would be open to considering third party takeover proposals for the Issuer. Ms. Wojcicki continues to evaluate and negotiate a transaction to acquire all of the Issuer’s outstanding shares of common stock not owned by her or her affiliates or any other stockholders she invites to “roll-over” their current equity shares.” NOTE: On August 1st, 23and Me also stated: “23andMe Holding, has received a preliminary non-binding indication of interest from Anne Wojcicki, Chief Executive Officer, Co-Founder, and Chair of the Board of Directors of 23andMe, to acquire all of the outstanding shares of 23andMe not owned by her or her affiliates or any other stockholder that she invites to roll over their shares for cash consideration of $0.40 per share of Class A Common Stock or Class B Common Stock. Ms. Wojcicki announced the Proposal on July 31, 2024 in a Schedule 13D filing with the Securities and Exchange Commission. The Special Committee previously formed by the Board of Directors of 23andMe is carefully reviewing and evaluating the Proposal and is committed to acting in the best interests of 23andMe and its shareholders.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ME:
- 23andMe updates clinical immuno-oncology programs 23ME-00610 at ESMO
- 23andMe to Present Updates on Clinical Immuno-oncology Programs 23ME-00610 and 23ME-01473 at ESMO Congress 2024
- 23andMe unit Lemonaid Health offering GLP-1 medication Ozempic and Wegovy
- Lemonaid Health Now Offering GLP-1 Medication Through Weight Loss Membership Program
- 23andMe Holding Executive Resigns, Therapeutics Division Closes
